Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study ...
An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.
WEDNESDAY, March 5, 2025 (HealthDay News) -- Sight-robbing injuries to the cornea can be repaired using a groundbreaking ...
12h
The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited conditions, is fueling the demand for advanced therapies, highlighting the need for strong ...
A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free ...
Scientists may have unlocked a new milestone in cancer treatment. An individual who received CAR T-cell therapy has been in ...
An expanded phase clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries ...
The residential cruise ship from Storylines aims to become the world’s first “blue zone” at sea by taking a holistic approach ...
Dr. Michael Wong, Roswell Park's new physician-in-chief, brings expertise in melanoma and rare skin cancers to Buffalo's ...
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...
8h
Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe ...
One of the pioneers of CAR T-cell therapy, Dr. Brentjens spoke with Becker's about what the new facility means for cancer innovation, as well as on how leaders across the U.S. can best integrate CAR T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback